FDA Publishes Immunogenicity Guidelines For Biosimilar Insulins

Biosimilar Insulins Generally Will Not Need Comparative Clinical Immunogenicity Data

 
• By Michael Cipriano
  
insulin hormone vials-single use syringe_1200x675
The US FDA is proposing streamlining development of biosimilar/interchangeable insulins • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products